Search

Your search keyword '"Pierce GN"' showing total 51 results

Search Constraints

Start Over You searched for: Author "Pierce GN" Remove constraint Author: "Pierce GN" Publication Year Range Last 10 years Remove constraint Publication Year Range: Last 10 years
51 results on '"Pierce GN"'

Search Results

1. Estimating the Potential Health Care Cost-Savings from a Flax-Based Treatment for Hypertension.

2. Beneficial Effects of Dietary Flaxseed on Non-Alcoholic Fatty Liver Disease.

3. Considerations for choosing an optimal animal model of cardiovascular disease.

4. Physiological and Pathological Considerations for the Use of Flaxseed as a Therapeutic Dietary Strategy.

5. The Remaining Conundrum of the Role of the Na + /H + Exchanger Isoform 1 (NHE1) in Cardiac Physiology and Pathology: Can It Be Rectified?

6. The Plasma Oxylipidome Links Smoking Status to Peripheral Artery Disease.

7. Bacteria and the growing threat of multidrug resistance for invasive cardiac interventions.

8. Molecular dynamics modeling of the Vibrio cholera Na + -translocating NADH:quinone oxidoreductase NqrB-NqrD subunit interface.

9. Dietary flaxseed reduces Myocardial Ischemic Lesions, improves cardiac function and lowers cholesterol levels despite the presence of severe obesity in JCR:LA-cp Rats.

10. The Impact of Nutrition on the COVID-19 Pandemic and the Impact of the COVID-19 Pandemic on Nutrition.

11. The Influence of Diet and Sex on the Gut Microbiota of Lean and Obese JCR:LA- cp Rats.

12. A Brief Review on the Biology and Effects of Cellular and Circulating microRNAs on Cardiac Remodeling after Infarction.

13. Oxidized phosphatidylcholines trigger ferroptosis in cardiomyocytes during ischemia-reperfusion injury.

14. Unexpected challenges for the translation of research on food interventions to applications in the food industry: using flaxseed research as an example.

15. N95 mask reuse in a major urban hospital: COVID-19 response process and procedure.

16. Cardioprotective Effects of Dietary Flaxseed Post-Infarction Are Associated with Changes in MicroRNA Expression.

17. The Cardioprotective Role of Flaxseed in the Prevention of Doxorubicin- and Trastuzumab-Mediated Cardiotoxicity in C57BL/6 Mice.

18. Dietary flaxseed protects against ventricular arrhythmias and left ventricular dilation after a myocardial infarction.

19. Phospholipid oxidation products in ferroptotic myocardial cell death.

20. Oxidized lipids: not just another brick in the wall 1 .

21. The effects of dietary flaxseed on cardiac arrhythmias and claudication in patients with peripheral arterial disease 1 .

22. Overcoming the Bitter Taste of Oils Enriched in Fatty Acids to Obtain Their Effects on the Heart in Health and Disease.

23. Dietary Flaxseed as a Strategy for Improving Human Health.

24. The Influence of Diet on MicroRNAs that Impact Cardiovascular Disease.

25. Ginseng Berry Extract Rich in Phenolic Compounds Attenuates Oxidative Stress but not Cardiac Remodeling post Myocardial Infarction.

26. Importance of functional food compounds in cardioprotection through action on the epigenome.

27. Dietary flaxseed: what we know and don't know about its effects on cardiovascular disease.

28. Do different nuclei in a binucleated cardiomyocyte have different rates of nuclear protein import?

29. Reduction of myocardial ischaemia-reperfusion injury by inactivating oxidized phospholipids.

30. Editorial / Éditorial.

31. Heat shock protein 60 involvement in vascular smooth muscle cell proliferation.

32. Flaxseed: its bioactive components and their cardiovascular benefits.

33. Alpha linolenic acid decreases apoptosis and oxidized phospholipids in cardiomyocytes during ischemia/reperfusion.

34. A review of the relative efficacy of dietary, nutritional supplements, lifestyle, and drug therapies in the management of hypertension.

35. Dietary modulation of oxylipins in cardiovascular disease and aging.

36. Na+-NQR (Na+-translocating NADH:ubiquinone oxidoreductase) as a novel target for antibiotics.

37. Specific plasma oxylipins increase the odds of cardiovascular and cerebrovascular events in patients with peripheral artery disease.

38. An output evaluation of a health research foundation's enhanced grant review process for new investigators.

39. Development of a novel rationally designed antibiotic to inhibit a nontraditional bacterial target.

40. Alarming Prevalence of Emergency Hypertension Levels in the General Public Identified by a Hypertension Awareness Campaign.

41. Dietary Flaxseed Reduces Central Aortic Blood Pressure Without Cardiac Involvement but Through Changes in Plasma Oxylipins.

42. Ruminant and industrial trans-fatty acid uptake in the heart.

43. The effect of flaxseed dose on circulating concentrations of alpha-linolenic acid and secoisolariciresinol diglucoside derived enterolignans in young, healthy adults.

45. A randomized trial of the effects of ezetimibe on the absorption of omega-3 fatty acids in cardiac disease patients: A pilot study.

47. Dietary flaxseed independently lowers circulating cholesterol and lowers it beyond the effects of cholesterol-lowering medications alone in patients with peripheral artery disease.

48. The toxicity of dietary trans fats.

49. Heat Shock Proteins: Mediators of Atherosclerotic Development.

50. Nuclear pore rearrangements and nuclear trafficking in cardiomyocytes from rat and human failing hearts.

Catalog

Books, media, physical & digital resources